3SBio (TRSBF) EBIT per Share : $0.13 (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is 3SBio EBIT per Share?

3SBio's EBIT per Share for the six months ended in Dec. 2023 was $0.05. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.13.

During the past 12 months, the average EBIT per Share Growth Rate of 3SBio was 26.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 17.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was 15.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for 3SBio's EBIT per Share or its related term are showing as below:

TRSBF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 8.2 Med: 15.5 Max: 32.6
Current: 17.8

During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of 3SBio was 32.60% per year. The lowest was 8.20% per year. And the median was 15.50% per year.

TRSBF's 3-Year EBIT Growth Rate is ranked better than
69.04% of 1305 companies
in the Biotechnology industry
Industry Median: 3.5 vs TRSBF: 17.80

3SBio's EBIT for the six months ended in Dec. 2023 was $127 Mil.

3SBio EBIT per Share Historical Data

The historical data trend for 3SBio's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio EBIT per Share Chart

3SBio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.08

0.06

0.11

0.13

3SBio Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.05	0.06	0.07	0.07	0.05

3SBio EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

3SBio's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	306.82	/	2441.666
=	0.13

3SBio's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	127.141	/	2439.819
=	0.05

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.13

3SBio (OTCPK:TRSBF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

3SBio EBIT per Share Related Terms

Thank you for viewing the detailed overview of 3SBio's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio (TRSBF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

01530:Hong Kong 83B:Germany

Address

No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027

Website

https://www.3sbio.com

3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

3SBio (TRSBF) Headlines

No Headlines